Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P Brevet1, A Curie2, C Princivil3

  • 1Service de rhumatologie, CHU de Rouen, 1, rue de Germont, 76031 Rouen, France.

La Revue De Medecine Interne
|December 11, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nefopam Misuse: A Cross-Sectional Study in France.

European journal of pain (London, England)·2025
Same author

Central nervous system vasculitis in VEXAS syndrome: A rare involvemen.

Clinical neurology and neurosurgery·2024
Same author

Intraventricular baclofen for palliative management of acquired generalized dystonia in pediatric patients: a case series and literature review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2023
Same author

A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy.

Neuromuscular disorders : NMD·2023
Same author

[HIV1 group M superinfection in a HIV1 group0-infected patient].

Virologie (Montrouge, France)·2021
Same author

[ANCA vasculitis preceded by isolated joint manifestations. Report of two cases and literature review].

La Revue de medecine interne·2021
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Anakinra, an anti-interleukin-1 receptor antagonist (IL-1RA), can cause rare but serious immune-allergic thrombocytopenia. This condition, marked by low platelets, rapidly resolved after stopping anakinra treatment.

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Anakinra is an interleukin-1 receptor antagonist (IL-1RA) that targets IL-1β, a key mediator in auto-inflammatory diseases.
  • While effective, anakinra treatment carries potential risks that require careful monitoring.

Observation:

  • A case of late-onset auto-inflammatory syndrome was treated with anakinra.
  • The patient developed severe, isolated thrombocytopenia during treatment.

Findings:

  • Thrombocytopenia rapidly improved and resolved after anakinra discontinuation.
  • This suggests an immuno-allergic mechanism triggered by anakinra.

Implications:

  • Immuno-allergic thrombocytopenia is a rare but significant adverse event associated with anakinra.
Keywords:
AnakinraAnti-IL-1RAAuto-inflammatory syndromeDrug-induced immune thrombocytopeniaIL-1Syndrome auto-inflammatoireThrombocytopénie immunitaire d’origine médicamenteuse

Related Experiment Videos

  • Clinicians should consider this diagnosis in patients on anakinra presenting with thrombocytopenia.
  • Early recognition and discontinuation of anakinra can lead to rapid recovery.